Clinical trialNAWithdrawn
Comparison Between the 19 and 22 Gauge Needles for Core Tissue Procurement During EUS-guided Procedures
- Outcome
- Stopped earlyPI decision was made to discontinue the study (Other)
- Phase
- NA
- Status
- Withdrawn
- Study type
- Interventional
- Start
- October 2013
- Expected end
- June 2015
- Enrollment
- 0 participants
- Sites
- 1
- Primary outcomes
- 22 gauge needle
- Sponsor
- Other
- Results posted
- No
- Last update
- 14 February 2017
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
The investigators hypothesis is that a 22 gauge needle can yield core tissue, obviating the need to use the 19 gauge needle for core tissue procurement.
Detailed description public domain (ClinicalTrials.gov)
Inclusion Criteria 1. Age under 19 years 2. Pregnant women will be excluded. This will be confirmed by self-report Exclusion Criteria 1. Age under 19 years 2. Pregnant women will be excluded. This will be confirmed by self-report